Cambridge Research Biochemicals acquires rights to novel technology useful for development of gene and drug therapies

Posted by & filed under News, Peptides.

Cambridge Research Biochemicals (CRB), a British company specialising in custom supply of research reagents, principally peptides and antibodies for medical research and the Pharmaceutical industry, today announced that it has licensed the rights to a novel and patentable method for parallel assembly of a large number of peptide-therapeutic cargo combinations